Cargando…

Recent Advances and Challenges of mTOR Inhibitors Use in the Treatment of Patients with Tuberous Sclerosis Complex

Tuberous sclerosis complex (TSC) is a genetic condition characterized by the presence of benign, noninvasive, and tumor-like lesions called hamartomas that can affect multiple organ systems and are responsible for the clinical features of the disease. In the majority of cases, TSC results from mutat...

Descripción completa

Detalles Bibliográficos
Autores principales: Palavra, Filipe, Robalo, Conceição, Reis, Flávio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5366202/
https://www.ncbi.nlm.nih.gov/pubmed/28386314
http://dx.doi.org/10.1155/2017/9820181